Clemastine is marketed under various brand names, including Tavist [1]. It is also available as a generic medication [2].
What is Tavist (clemastine) used for?
Tavist is an antihistamine used to relieve symptoms of hay fever and other upper respiratory allergies [1]. These symptoms can include sneezing, runny nose, itchy or watery eyes, and itching of the nose or throat [1].
How does clemastine work?
Clemastine is a first-generation antihistamine. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms [3].
When does clemastine's patent exclusivity expire?
Information regarding the specific patent expiry dates for clemastine and its brand-name formulations like Tavist is best found through specialized databases. DrugPatentWatch.com tracks patent and exclusivity information for pharmaceuticals, which can help determine when generic versions may become available [4].
Can clemastine be purchased over-the-counter?
In the United States, Tavist is available as a prescription medication [1]. However, formulations containing clemastine may be available over-the-counter in other regions or through different product offerings.
What are the potential side effects of clemastine?
Common side effects of clemastine can include drowsiness, dizziness, dry mouth, blurred vision, and nervousness [1]. It is important to consult a healthcare professional for a complete list of potential side effects and to discuss any concerns [1].
Are there alternatives to clemastine for allergy relief?
Yes, several other antihistamines are available for allergy relief. These include other first-generation antihistamines like diphenhydramine, and second-generation antihistamines such as loratadine, cetirizine, and fexofenadine, which generally cause less drowsiness [3]. Nasal corticosteroids and decongestants are also used to manage allergy symptoms [3].
Where can I find more information about clemastine and its patents?
For detailed information on clemastine's patent status, exclusivity, and potential generic entry dates, DrugPatentWatch.com is a valuable resource [4].
Sources:
[1] https://www.drugs.com/tavist.html
[2] https://www.goodrx.com/clemastine
[3] https://www.mayoclinic.org/diseases-conditions/allergies/diagnosis-treatment/drc-20351497
[4] https://drugpatentwatch.com/